Advanced search
1 file | 255.29 KB Add to list

Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials

(2011) VACCINE. 29(6). p.1159-1166
Author
Organization
Keywords
PROTECTION, PERSISTENCE, HB-AS02, Adjuvant, HEMODIALYSIS-PATIENTS, SEROCONVERSION, VIRUS-INFECTION, EFFICACY, Dialysis, Hepatitis B, Vaccination, ADJUVANT SYSTEMS, LONG-TERM IMMUNOGENICITY, IMMUNITY, ANTIGEN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 255.29 KB

Citation

Please use this url to cite or link to this publication:

MLA
Tielemans, Christian L, Jiri Vlasak, Dezider Kosa, et al. “Immunogenicity and Safety of an Investigational AS02v-adjuvanted Hepatitis B Vaccine in Patients with Renal Insufficiency Who Failed to Respond or to Maintain Antibody Levels After Prior Vaccination: Results of Two Open, Randomized, Comparative Trials.” VACCINE 29.6 (2011): 1159–1166. Print.
APA
Tielemans, C. L., Vlasak, J., Kosa, D., Billiouw, J.-M., Verpooten, G. A., Mezei, I., Ryba, M., et al. (2011). Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials. VACCINE, 29(6), 1159–1166.
Chicago author-date
Tielemans, Christian L, Jiri Vlasak, Dezider Kosa, Jean-Marie Billiouw, Gert A Verpooten, Ilona Mezei, Miroslav Ryba, et al. 2011. “Immunogenicity and Safety of an Investigational AS02v-adjuvanted Hepatitis B Vaccine in Patients with Renal Insufficiency Who Failed to Respond or to Maintain Antibody Levels After Prior Vaccination: Results of Two Open, Randomized, Comparative Trials.” Vaccine 29 (6): 1159–1166.
Chicago author-date (all authors)
Tielemans, Christian L, Jiri Vlasak, Dezider Kosa, Jean-Marie Billiouw, Gert A Verpooten, Ilona Mezei, Miroslav Ryba, PATRICK PEETERS, Olivier Mat, Michel Y Jadoul, Vladimir Polakovic, Michel Dhaene, Serge Treille, Sherine O Kuriyakose, Maarten Leyssen, Sophie A Houard, and Murielle Surquin. 2011. “Immunogenicity and Safety of an Investigational AS02v-adjuvanted Hepatitis B Vaccine in Patients with Renal Insufficiency Who Failed to Respond or to Maintain Antibody Levels After Prior Vaccination: Results of Two Open, Randomized, Comparative Trials.” Vaccine 29 (6): 1159–1166.
Vancouver
1.
Tielemans CL, Vlasak J, Kosa D, Billiouw J-M, Verpooten GA, Mezei I, et al. Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials. VACCINE. 2011;29(6):1159–66.
IEEE
[1]
C. L. Tielemans et al., “Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials,” VACCINE, vol. 29, no. 6, pp. 1159–1166, 2011.
@article{2939592,
  author       = {Tielemans, Christian L and Vlasak, Jiri and Kosa, Dezider and Billiouw, Jean-Marie and Verpooten, Gert A and Mezei, Ilona and Ryba, Miroslav and Peeters, Patrick and Mat, Olivier and Jadoul, Michel Y and Polakovic, Vladimir and Dhaene, Michel and Treille, Serge and Kuriyakose, Sherine O and Leyssen, Maarten and Houard, Sophie A and Surquin, Murielle},
  issn         = {0264-410X},
  journal      = {VACCINE},
  keywords     = {PROTECTION,PERSISTENCE,HB-AS02,Adjuvant,HEMODIALYSIS-PATIENTS,SEROCONVERSION,VIRUS-INFECTION,EFFICACY,Dialysis,Hepatitis B,Vaccination,ADJUVANT SYSTEMS,LONG-TERM IMMUNOGENICITY,IMMUNITY,ANTIGEN},
  language     = {eng},
  number       = {6},
  pages        = {1159--1166},
  title        = {Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials},
  url          = {http://dx.doi.org/10.1016/j.vaccine.2010.12.009},
  volume       = {29},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: